Td Asset Management Inc Amneal Pharmaceuticals, Inc. Transaction History

Td Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$2.65 - $5.56 $709,691 - $1.49 Million	-267,808 Closed	0 $0
Q3 2019 Nov 07, 2019	SELL	$2.29 - $7.1 $394,720 - $1.22 Million	-172,367 Reduced 39.16%	267,808 $777,000
Q2 2019 Aug 01, 2019	SELL	$6.44 - $14.29 $270,480 - $600,180	-42,000 Reduced 8.71%	440,175 $3.16 Million
Q1 2019 May 08, 2019	BUY	$11.87 - $14.84 $181,611 - $227,052	15,300 Added 3.28%	482,175 $6.83 Million
Q4 2018 Feb 01, 2019	BUY	$13.09 - $21.49 $3.04 Million - $4.99 Million	232,043 Added 98.81%	466,875 $6.32 Million
Q3 2018 Nov 01, 2018	BUY	$16.4 - $24.27 $3.85 Million - $5.7 Million	234,832 New	234,832 $5.21 Million

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.25B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.